12.07.2023 15:32:00 - EQS-Adhoc: Limes Schlosskliniken AG: LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG

===
EQS-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Expansion/Investment
Limes Schlosskliniken AG: LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG
12-Jul-2023 / 15:32 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News
- a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP-Adhoc: LIMES Schlosskliniken AG:
LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG
LIMES Schlosskliniken AG, Cologne/Gaflei, FL, July 12, 2023. LIMES Schlosskliniken AG has acquired 51% of the
Liechtenstein private clinic CLINICUM ALPINUM AG via a capital increase. 49% of the shares continue to be held by the
founding Risch family and further Liechtenstein investors.
The CLINICUM ALPINUM has been opened in 2019 and focuses primarily on mental diseases, such as depression and
stress-related disorders. The clinic is located in an alpine setting at 1,483 meters above sea level and offers an
individualized treatment plan as well as high-frequency psychotherapy and a wide range of individually tailored special
therapies. Nestled in the Liechtenstein mountains, the Healing-Environment-Concept for mental diseases has been
implemented to the highest quality.
The CLINICUM ALPINUM and the LIMES Schlosskliniken will strengthen the international orientation of the clinic with the
existing team around the chief medical officer Marc Risch. The new partnership offers all the prerequisites for this.
The capital increase by LIMES Schlosskliniken AG will be financed from liquid funds of the LIMES Group.

Corporate profiles:
The CLINICUM ALPINUM opened in 2019 and has been successfully positioned as a private Liechtenstein acute clinic for
the treatment of depression and stress-related diseases. The clinic, in a unique location, has a total of 50 treatment
places. More information is available at www.clinicum-alpinum.com.
The LIMES Schlosskliniken Group operates high-quality private clinics in Germany for stress-related diseases, mental
and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is
aimed at private patients, those entitled to state aid and self-payers. The LIMES Schlosskliniken Group stands for the
special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to
top medical quality, patients are offered a unique, protected and healing environment in which they can recover
holistically. Further information is available at www.limes-schlosskliniken.de.
Your contact person:
LIMES Schlosskliniken AG, Petra Kaes, Investor Relations
Kaiser-Wilhelm-Ring 26, 50672 Cologne
Tel.: 0221/669 615 10, p.kaes@limes.care
Language: German
Company: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Cologne, Germany
Phone:   49 221 669 615 10 
Mail:  p.kaes@limes.care 
Internet:  www.limes-schlosskliniken.de 
ISIN:  DE000A0JDBC7 
WKN:  AOJDBC 

Stock exchange: Düsseldorf Open Market, Primary Market, XETRA
End of the message

End of Inside Information
12-Jul-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press
Releases.
Archive at www.eqs-news.com  
Language:     English 
Company:      Limes Schlosskliniken AG 

Kaiser-Wilhelm-Ring 26
50672 Köln
Germany
ISIN:         DE000A0JDBC7 
WKN:          A0JDBC 
Listed:       Regulated Unofficial Market in Dusseldorf 
EQS News ID:  1678729 


End of Announcement EQS News Service
===
1678729 12-Jul-2023 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1678729&application_name=news

END) Dow Jones Newswires

July 12, 2023 09:32 ET (13:32 GMT)
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
LIMES SCHLOSSKLINIK. O.N. A0JDBC Xetra 352,000 07.06.24 17:36:08 +2,000 +0,57% 0,000 0,000 350,000 352,000

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH